STJ Insider Trading Activity and SEC Form 4 Filings
STJ insider trading summary
No open-market insider purchases or sales of St Jude Medical Inc (STJ) have been reported on SEC Form 4 in the past 12 months.
Latest STJ insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 5, 2016 | Jeff Fecho | VP, Global Quality | Sell | $538K (10,408 @ $51.71) |
| Dec 21, 2015 | Donald Zurbay | VP Finance and CFO | Sell | $189K (3,106 @ $60.96) |
| Dec 21, 2015 | Jeff Dallager | VP and Corporate Controller | Sell | $31K (501 @ $60.94) |
| Dec 18, 2015 | John C Heinmiller | Executive Vice President | Sell | $490K (8,009 @ $61.16) |
| Nov 2, 2015 | Scott Thome | VP, Global Ops & Supply Chain | Sell | $103K (1,596 @ $64.37) |
| Nov 2, 2015 | Scott Thome | VP, Global Ops & Supply Chain | Sell | $193K (2,999 @ $64.34) |
| Nov 2, 2015 | Jason Zellers | VP, General Counsel & Corp Sec | Sell | $857K (13,333 @ $64.29) |
| Oct 31, 2015 | Jason Zellers | VP, General Counsel & Corp Sec | Sell | $19K (294 @ $64.66) |
| Oct 28, 2015 | Daniel J Starks | Chairman, CEO & President | Sell | $264K (4,214 @ $62.68) |
| Oct 28, 2015 | Daniel J Starks | Chairman, CEO & President | Sell | $7.2M (115,786 @ $62.35) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.